Last update :
18/04/2024
Anticancer drug   Epirubicin hydrochloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Anthracine Malaysia
Axirubicine Germany
Bendaepi Germany
Binarin Mexico
Bioepycina Poland
Crisabon Argentina
Cuatroepi Argentina
Ecclepia Romania
Elebicin Mexico
Ellence United States of America
Epi Cell Germany
Epidoxo Argentina, Chile, Venezuela
Epifil Ecuador
Epilem Colombia, Mexico
Epimedac Germany
Epirubicin Australia, Austria, Belgium, Denmark, Great Britain, Hungary, Iceland, New Zealand, Saudi Arabia, Sweden, Switzerland, Turkey
Epirubicina Argentina, Colombia, Ecuador, Mexico, Romania, Spain
Epirubicine Belgium, France, Switzerland
Farmarubicin Turkey
Farmorubicin Austria, Brazil, Denmark, Finland, Greece, Norway, Saudi Arabia, Sweden, Switzerland
Farmorubicin CSV Republic of South Africa
Farmorubicin PFS Croatia, Poland, Slovenia
Farmorubicin RD Brazil, Poland, Russian, Switzerland
Farmorubicin RTU Netherlands
Farmorubicina Brazil, Italy, Portugal, Spain
Farmorubicine Belgium, France
Pharmorubicin Great Britain
Compatibility   Injection   Compatibility : Epirubicin hydrochloride              
This screen indicates the compatibilities or incompatibilities with, in this case, the type of incompatibility (precipitation, color change, modification of an emulsion, etc.). The compatibilities shown here are mostly physical only, with the chemical stability of each molecule rarely being assessed. The evaluation of these mixtures was studied to consider the possibility of Y-site administration to the patient. These data cannot be used for making mixtures in advance in bags or syringes. This type of information is available in the screen "Stability in mixture ».
Compound Solvent References

  Mentions Légales